Walvax Biotechnology Co., Ltd.
300142
Rang în acțiuni
#4861
Walvax Biotechnology Co., Ltd. operates as a biological pharmaceutical... Walvax Biotechnology Co., Ltd. operates as a biological pharmaceutical enterprise, dedicated to the research, development, manufacturing, and commercialization of biopharmaceutical products within the Chinese market. Its product portfolio encompasses a range of biomedicines, notably vaccines, blood products, and other related treatments. A significant portion of Walvax's vaccine offerings addresses meningococcal diseases. This includes a Group A, C meningococcal polysaccharide conjugate vaccine for infants up to two years, which prevents conditions such as cerebrospinal meningitis and septicemia. For older children (above two years) and adults, they offer a Group A and C meningococcal polysaccharide vaccine, designed to protect against infections from Neisseria meningitidis serogroups A or C. Furthermore, the company provides a Group ACYW135 meningococcal polysaccharide vaccine, aimed at children over two years old, to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis serogroups A, C, Y, and W135. Beyond meningococcal vaccines, the company supplies a Haemophilus influenzae type b conjugate vaccine, crucial for children aged two months to five years in preventing severe infectious diseases like meningitis, pneumonia, septicemia, cellulitis, arthritis, and epiglottitis. It also manufactures a combined diphtheria, tetanus, and acellular pertussis vaccine for individuals between three months and six years, safeguarding against these three infectious illnesses. Lastly, a 23-valent pneumococcal polysaccharide vaccine is offered for children over two years old, providing immunity against pneumococcal disease caused by 23 distinct serotypes. Established in 2001, Walvax Biotechnology Co., Ltd. maintains its headquarters in Kunming, China.
Preț acțiune
$1.87
Capitalizare de piață
$2.98B
Schimbare (1 zi)
-3.71%
Schimbare (1 an)
14.73%
Țară
CN
Tranzacționează Walvax Biotechnology Co., Ltd. (300142)
Categorie
Healthcare
Istoric dividende pentru Walvax Biotechnology Co., Ltd. (300142)
Walvax Biotechnology Co., Ltd. (simbol acțiune: 300142) a efectuat un total de 13 plăți de dividende.
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: $0.39
Randamentul dividendului (TTM): 0.0124
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: $0.39
Randamentul dividendului (TTM): 0.0124
Plăți de dividende pentru Walvax Biotechnology Co., Ltd. (300142) din 2011 până în 2026
Plăți anuale de dividende
| An | Dividend (ajustat pentru split de acțiuni) | Schimbă |
|---|---|---|
| 2026 (TTM) | $0.125 | 1,150.00% |
| 2025 | $0.01 | 0.00% |
| 2024 | $0.01 | 0.00% |
| 2023 | $0.01 | -62.96% |
| 2022 | $0.027 | -46.00% |
| 2021 | $0.05 | 150.00% |
| 2020 | $0.02 | -33.33% |
| 2019 | $0.03 | 261.45% |
| 2015 | $0.0083 | 0.00% |
| 2014 | $0.0083 | -74.14% |
| 2013 | $0.0321 | 0.00% |
| 2011 | $0.0321 | 0.00% |
Lista tuturor plăților de dividende
| An | Dividend | Schimbă |
|---|---|---|
| 2026 (TTM) | $0.125 | 1,150.00% |
| 2025 | $0.01 | 0.00% |
| 2024 | $0.01 | 0.00% |
| 2023 | $0.01 | -62.96% |
| 2022 | $0.027 | -46.00% |
| 2021 | $0.05 | 150.00% |
| 2020 | $0.02 | -33.33% |
| 2019 | $0.03 | -40.00% |
| 2015 | $0.05 | -23.08% |
| 2014 | $0.065 | -74.00% |
| 2013 | $0.25 | -16.67% |
| 2011 | $0.3 | 0.00% |
Dividende ale companiilor similare sau concurente
| Companie | Număr de plăți de dividende | Țara |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 2.00% |
CH
|
|
| 39.00% |
IN
|
